An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa — and the approach...

The Walter Reed Army Institute of Research (WRAIR) announced this week the initiation of a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both...

A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated...

A new weapon in the arsenal in the fight against Ebola has a Mount St. Mary’s University researcher hopeful that progress is being made toward finding a cure for the devastating viral disease. A recently-tested...

“This is Guinea’s gift to West Africa and the world,” said Dr Sakoba Keita, Guinea’s national coordinator for the Ebola response. “The thousands of volunteers from Conakry and other...

The Centers for Disease Control and Prevention (CDC), in partnership with the Sierra Leone College of Medicine and Allied Health Sciences (COMAHS) and the Sierra Leone Ministry of Health and Sanitation...

In an update on the patient being treated for Ebola Virus Disease (EVD) at the NIH Clinical Center in Bethesda, MD, officials say the patient has improved from critical to serious condition. Ring vaccination...

Multiple health agencies will be launching the Phase III trial for the Ebola vaccine, VSV-EBOV, in Guinea on Saturday, according to the World Health Organization. According to reports, the initial...

GSK has announced that the first batch of its candidate Ebola vaccine is being shipped to west Africa and is expected to arrive in Liberia later today Friday 23 January. The shipment, containing an initial...

Johnson & Johnson (NYSE: JNJ) is pleased to announce the formation of consortia with leading global research institutions and non-government organizations to work in conjunction with Janssen Pharmaceutical...